Amgen Inc. Stock Performance
as on June 27, 2026 at 6:59 am IST
Day's Low
Day's High
$354.16$362.03
1.16%
Downside
1.04%
Upside
52 Week's Low
52 Week's High
$269.77$391.2924.71%
Downside
9.20%
Upside
Amgen Inc. share price movements today
- Previous Close
- $352.82
- Open
- $354.65
- Volume
- 1.4M
- Day's Low - High
- $354.16 - $362.03
- 52 Week Low - High
- $269.77 - $391.29
Amgen Inc. Historical Returns
- 1 Month Return
- + 5.02 %
- 3 Month Return
- -0.1 %
- 1 Year Return
- + 26.41 %
- 3 Year Return
- + 57 %
- 5 Year Return
- + 45.38 %
Amgen Inc. Stock Fundamentals & Key Indicators
Check Amgen Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$189.7B
EPS (TTM)
22.3879
Dividend Yield
2.78%
Quarterly Earnings Growth YOY
0.04%
PE Ratio (TTM)
24.46
Industry PE ratio
12.2625
PEG Ratio
2.3227
EBITDA
16.9B
Revenue (TTM)
37.2B
Profit Margin
20.96%
Return On Equity TTM
101.32%
Amgen Inc. Stock Valuation
Track how Amgen Inc. P/E has moved over time to understand its valuation trends.
Amgen Inc. in the last 5 years
Lowest (12.34x)
December 31, 2021
Industry (12.26x)
June 26, 2026
Today (24.46x)
June 26, 2026
Highest (19.03x)
March 31, 2026
Today’s Price to Earnings Ratio: 24.46x
Amgen Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Amgen Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $189.7B | 45.38% | 24.46 | 20.96% | 2.78% | |
| BUY | $286.9B | 212.86% | 27.86 | 17.19% | 1.7500000000000002% | |
| BUY | $996.3B | 389.83% | 39.69 | 34.99% | 0.5599999999999999% | |
| BUY | $415.0B | 115.21% | 115.14 | 5.79% | 2.87% | |
| BUY | $580.1B | 49.13% | 27.93 | 21.83% | 2.18% |
Stock Returns calculator for Amgen Inc. Stock including INR - Dollar returns
The Amgen Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Amgen Inc. investment value today
Current value as on today
₹1,41,489
Returns
₹41,489
(+41.49%)
Returns from Amgen Inc. Stock
₹28,379 (+28.38%)
Dollar Impact
₹13,109 (+13.11%)
Analyst Recommendation on Amgen Inc. Stock
Based on 37 analysts
56.76%
Buy
35.14%
Hold
8.11%
Sell
Based on 37 analysts, 56.76% of analysts recommend a 'BUY' rating for Amgen Inc.. Average target price of $352.77
Amgen Inc. Share Price Target
Get share price movements and forecasts by analysts on Amgen Inc..
What analysts predicted
-1.57%DOWNSIDE
Target Price
$352.77
Current Price
$358.32
Analyzed by
37 Analysts
Target
$352.77
Amgen Inc. target price $352.77, a slight downside of -1.57% compared to current price of $358.32. According to 37 analysts rating.
Indian Investors' Interest in Amgen Inc. Stock
Search interest for Amgen Inc. Stock has increased by 19% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:19% versus previous 30 day period
Amgen Inc. Quarterly Profit & Loss
All numbers in Millions USD
Amgen Inc. Annual Profit & Loss
All numbers in Millions USD
Amgen Inc. Quarterly Cash Flow
All numbers in Millions USD
Amgen Inc. Annual Cash Flow
All numbers in Millions USD
Mutual Funds that own Amgen Inc. Stock
Check out the Mutual Funds with significant holdings in Amgen Inc..
Funds | Holdings | Shares Held |
|---|---|---|
 ICICI Prudential NASDAQ 100 Index Fund Direct Growth | 0.79673% | 9002 |
 Motilal Oswal S&P 500 Index Fund Direct Growth | 0.27634% | 3956 |
 Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth | 1.31641% | 730 |
Global Institutional Holdings in Amgen Inc.
Amgen Inc. News & Key Events
Today's Timeline - 26 June
Fri, 04:41 PM
-Piper Sandler and Morgan Stanley highlight Amgen's pipeline strength and obesity drug potential, maintaining positive ratings.
Fri, 05:33 PM
-European Medicines Agency calls for revocation of Amgen's Tavneos marketing authorization due to data integrity issues.
Insights on Amgen Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Amgen Inc. Common Stock has shown positive profit growth over the last two quarters, with net profit increasing from $1.33 billion to $1.81 billion. This represents an average increase of 26.7% each quarter.
- POSITIVE IMPACT
Price Rise
In the last 7 days, AMGN stock has moved up by 4.5%
NO EFFECTAgainst Peers
In the last 1 year, AstraZeneca PLC has given 165.0% return, outperforming this stock by 138.6%
- NO EFFECT
Against Peers
In the last 3 years, AstraZeneca PLC has given 158.9% return, outperforming this stock by 101.9%
NEGATIVE IMPACTRevenue Fall
Amgen Inc. Common Stock has experienced a decline in revenue over the last two quarters. Revenue decreased from $9.89 billion to $8.61 billion, averaging a decrease of 12.9% per quarter.
About Amgen Inc.
| Organisation | Amgen Inc. |
| Headquarters | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 |
| Industry | Drug Manufacturers - General |
| CEO | Mr. Robert A. Bradway |
| E-voting on shares | Click here to vote |
Key Management of Amgen Inc.
Name | Title |
|---|---|
Mr. Robert A. Bradway | Chairman & CEO |
Mr. Murdo Gordon | EVP of Global Markets & Policy, Medical, Commercial Operations, Government Affairs and Policy |
Mr. Matthew C. Busch | Chief Accounting Officer & VP of Finance |
Mr. Howard Y. Chang M.D., Ph.D. | Senior VP of Global Research & Chief Scientific Officer |
Casey Capparelli | Executive Director of Investor Relations |
Mr. Peter H. Griffith | Executive VP & CFO |
Dr. David M. Reese M.D. | Executive VP & CTO |
Dr. James E. Bradner M.D. | EVP of Research & Development, Artificial Intelligence and Data |
Mr. Esteban Santos | Executive Vice President of Operations |
Mr. Scott Skellenger | Senior VP & Chief Information Officer |
FAQs
What is Amgen Inc. share price today?
Amgen Inc. share price today is $358.32 as on at the close of the market. Amgen Inc. share today touched a day high of $362.03 and a low of $354.16.
What is the 52 week high and 52 week low for Amgen Inc. share?
Amgen Inc. share touched a 52 week high of $391.29 on and a 52 week low of $269.77 on . Amgen Inc. stock price today i.e. is closed at $358.32,which is 8.43% down from its 52 week high and 32.82% up from its 52 week low.
What is Amgen Inc.'s market capitalisation today?
Amgen Inc. market capitalisation is $0.19T as on .
How to invest in Amgen Inc. Stock (AMGN) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Amgen Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Amgen Inc. Shares that will get you 0.0042 shares as per Amgen Inc. share price of $358.32 per share as on June 27, 2026 at 1:29 am IST.
What is the minimum amount required to buy Amgen Inc. Stock (AMGN) from India?
Indian investors can start investing in Amgen Inc. (AMGN) shares with as little as ₹94.385 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.85 in Amgen Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Amgen Inc. share’s latest price of $358.32 as on June 27, 2026 at 1:29 am IST, you will get 0.0279 shares of Amgen Inc.. Learn more about
fractional shares .
What are the returns that Amgen Inc. has given to Indian investors in the last 5 years?
Amgen Inc. stock has given 45.38% share price returns and 27.55% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?